Christopher Hillyer

Christopher D.
Hillyer, MD is President and CEO, New York Blood Center Enterprises (NYBCe), Inc; General Partner, NYBC Ventures; Chief Scientific Officer and Distinguished Investigator, Lindsley F.
Kimball Research Institute; and Professor, Department of Medicine, Weill Cornell College of Medicine Dr. Hillyer is editor of 13 textbooks in transfusion medicine including the 16-18th editions of the AABB Technical Manual and Hillyer’s Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects, now in its 4th edition, continues a primary resource for physicians throughout the world.
Author of over 175 articles pertaining to transfusion, human immunodeficiency virus, and herpes viruses, hematopoietic stem cells, and terminal erythrocyte differentiation, Dr. Hillyer has been awarded tens of millions of dollars in research funding from the National Institutes of Health, the Centers for Disease Control and Prevention, and other agencies.
Hillyer held T, U, R01, and P01 grants and contracts and PI including detailed studies using large cohorts of non-human primates as a model for HIV/AIDS at the Emory National Primate Research Center.
Dr. Hillyer received AABB’s Emily Cooley Award for his “significant commitment and contributions to the field of transfusion medicine…”, an AABB’s President’s Award, and two iterative Tiffany Awards from the American Red Cross for his work in Africa as co-director of the AABB/Emory cooperative agreement, part of the President’s Emergency Plan For AIDS Relief (PEPFAR).
Dr. Hillyer is board certified in internal medicine, hematology, medical oncology and transfusion medicine.
He received his BS with honors from Trinity College and his MD from the University of Rochester School of Medicine, with postgraduate training and fellowships in hematology-oncology, transfusion medicine, and bone marrow transplantation at Tufts-New England Medical Center in Boston.